Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome

被引:6
|
作者
Sarray, Sameh [1 ]
Almawi, Wassim Y. [1 ]
机构
[1] Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain
关键词
CD40L; CRP; cytokines; polycystic ovary syndrome; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; GRADE CHRONIC INFLAMMATION; NORMAL-WEIGHT WOMEN; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; SOLUBLE CD40L; PER-SE;
D O I
10.1111/aji.12549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Problem: We investigated whether changes in sCD40L, hs-CRP, IL-6, and TNF-alpha levels are associated with polycystic ovary syndrome (PCOS). Method of study: Case-control study involving 143 women with and 165 women without PCOS. Result(s): Reduced sCD40L, and increased hs-CRP and IL-6, but not TNF-alpha, levels were seen between cases and controls. ROC analysis demonstrated high sensitivity and specificity for sCD40L and hs-CRP as PCOS predictors. Altered sCD40L levels were associated with PCOS, irrespective of body weight. Significant differences in IL-6 levels were seen between non-obese subjects and for TNF-alpha in obese subjects. sCD40L correlated negatively with age, insulin, HOMA-IR, LH, free testosterone, FAI, and hirsutism, but positively with SHBG. CRP correlated positively with BMI, insulin, HOMA-IR, free testosterone, and hirsutism. IL-6 correlated positively with hirsutism. TNF-alpha correlated positively with age, but negatively with insulin and HOMA-IR. Conclusion: CD40L, more than IL-6, or TNF-alpha, constitutes a predictor to explain PCOS and associated features.
引用
下载
收藏
页码:285 / 291
页数:7
相关论文
共 50 条
  • [21] Distinct Genetic Susceptibility Patterns of the Obese and Non-obese South Indian Women with Polycystic Ovary Syndrome
    Reddy, B. Mohan
    Irgam, Kumuda
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2021, 21 (01) : 1 - 7
  • [22] Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling
    Romero-Ruiz, Antonio
    Pineda, Beatriz
    Ovelleiro, David
    Perdices-Lopez, Cecilia
    Torres, Encarnacion
    Vazquez, Maria J.
    Guler, Ipek
    Jimenez, Alvaro
    Pineda, Rafael
    Persano, Mariasara
    Romero-Baldonado, Cristina
    Arjona, Jose E.
    Lorente, Juan
    Munoz, Concepcion
    Paz, Elier
    Garcia-Maceira, Fe-Isabel
    Arjona-Sanchez, Alvaro
    Tena-Sempere, Manuel
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (05) : 637 - 652
  • [23] Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome
    Recep Yildizhan
    Mertihan Kurdoglu
    Ertan Adali
    Ali Kolusari
    Begum Yildizhan
    Hanim Guler Sahin
    Mansur Kamaci
    Archives of Gynecology and Obstetrics, 2009, 280
  • [24] Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome
    Yildizhan, Recep
    Kurdoglu, Mertihan
    Adali, Ertan
    Kolusari, Ali
    Yildizhan, Begum
    Sahin, Hanim Guler
    Kamaci, Mansur
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (04) : 559 - 563
  • [25] Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis
    Raeisi, Tahereh
    Rezaie, Hossein
    Darand, Mina
    Taheri, Akram
    Garousi, Nazila
    Razi, Bahman
    Roever, Leonardo
    Mohseni, Reza
    Mohammed, Shimels Hussien
    Alizadeh, Shahab
    PLOS ONE, 2021, 16 (03):
  • [26] Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome
    Rautio, K
    Tapanainen, JS
    Ruokonen, A
    Morin-Papunen, LC
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (02) : 269 - 275
  • [27] Serum polychlorinated biphenyl levels and circulating miRNAs in non-obese women with and without polycystic ovary syndrome
    Brennan, Edwina
    Butler, Alexandra E.
    Drage, Daniel S.
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Metabolic abnormalities in polycystic ovary syndrome women: obese and non obese
    Maltoni Romano, Lucas Gabriel
    Bedoschi, Giuliano
    Sanches Melo, Anderson
    Oliveira de Albuquerque, Felipe
    Japur de Sa Rosa e Silva, Ana Carolina
    Ferriani, Rui Alberto
    Navarro, Paula Andrea
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2011, 33 (06): : 310 - 316
  • [29] Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters
    U. Durmus
    C. Duran
    S. Ecirli
    Journal of Endocrinological Investigation, 2017, 40 : 487 - 497
  • [30] Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters
    Durmus, U.
    Duran, C.
    Ecirli, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (05): : 487 - 497